Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chung-Shan Yu
Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma
Oncotarget
Oncology
18f-Glutathione Conjugate as a PET Tracer for Imaging Tumors That Overexpress L-PGDS Enzyme
PLoS ONE
Multidisciplinary
Related publications
Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer
PLoS ONE
Multidisciplinary
RETRACTED: Proteomics-Based Identification of Α-Enolase as a Potential Prognostic Marker in Cholangiocarcinoma
Clinical Biochemistry
Medicine
Clinical Biochemistry
Clinical Importance of S100A9 in Osteosarcoma Development and as a Diagnostic Marker and Therapeutic Target
Bioengineered
Applied Microbiology
Biotechnology
Medicine
Bioengineering
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
PLoS ONE
Multidisciplinary
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
PLoS ONE
Multidisciplinary
623 CRD-BP as a Potential Prognostic Marker and Therapeutic Target in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Identification of Glycogen Synthase Kinase 3α as a Therapeutic Target in Melanoma
Pigment Cell and Melanoma Research
Biochemistry
Dermatology
Oncology
Genetics
Molecular Biology
Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis
British Journal of Cancer
Cancer Research
Oncology
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology